Baker Brothers Advisors - ACHILLES THERAPEUTICS PLC ownership

ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 26 filers reported holding ACHILLES THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of ACHILLES THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$2,326,750
-3.7%
2,557,1490.0%0.01%
-7.1%
Q2 2023$2,417,017
-2.6%
2,557,149
-1.3%
0.01%
+7.7%
Q1 2023$2,481,233
+6.4%
2,591,3660.0%0.01%
-7.1%
Q4 2022$2,332,229
-60.2%
2,591,3660.0%0.01%
-63.2%
Q3 2022$5,856,000
-10.3%
2,591,3660.0%0.04%
+2.7%
Q2 2022$6,530,000
-14.3%
2,591,3660.0%0.04%
-15.9%
Q1 2022$7,619,000
-41.3%
2,591,3660.0%0.04%
-30.2%
Q4 2021$12,983,000
-35.7%
2,591,3660.0%0.06%
-29.2%
Q3 2021$20,187,000
-20.4%
2,591,3660.0%0.09%
-19.8%
Q2 2021$25,369,000
-40.8%
2,591,3660.0%0.11%
-40.3%
Q1 2021$42,887,0002,591,3660.19%
Other shareholders
ACHILLES THERAPEUTICS PLC shareholders Q2 2022
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 11,086,909$10,087,97915.03%
Artal Group S.A. 2,255,375$2,0520.09%
Redmile Group, LLC 1,608,089$1,463,2000.07%
Forefront Analytics, LLC 78,169$71,1260.04%
Baker Brothers Advisors 2,557,149$2,326,7500.01%
Point72 Asset Management, L.P. 1,413,809$1,286,4250.00%
XTX Topco Ltd 21,084$19,1840.00%
Coppell Advisory Solutions LLC 1,000$5,5600.00%
Renaissance Technologies 437,528$3980.00%
JPMORGAN CHASE & CO 989$9000.00%
View complete list of ACHILLES THERAPEUTICS PLC shareholders